Recorded Chinese product: 乙酰半胱氨酸滴眼液乙酰半胱氨酸滴眼液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司
主要成分Active Ingredients
- 按平均装量计Anping Junzhuang Liangji
药物知识说明
按平均装量计是一种在国家药监局注册认定的药品。标注生产企业为江苏吉贝尔药业股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司、江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司、江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 乙酰半胱氨酸滴眼液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 江苏吉贝尔药业股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司, 江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司, 江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 乙酰半胱氨酸滴眼液Recorded Chinese product: 乙酰半胱氨酸滴眼液
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 粉剂每瓶80mg，溶剂每瓶5mlRecorded Chinese description: 粉剂每瓶80mg，溶剂每瓶5ml
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 江苏吉贝尔药业股份有限公司Chinese legal name: 江苏吉贝尔药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32025716
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32025716
Manufacturer
Chinese legal name: 江苏吉贝尔药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32025716
生产企业
江苏吉贝尔药业股份有限公司(国产)
适应症
1.状角膜炎和单纯疱疹性角膜炎；细菌性（包括病毒）角膜溃疡。 2.其它角膜溃疡包括春季卡他性继发角膜溃疡；角膜烧伤、角膜实质炎、水汽性角膜炎、干燥性角膜炎继发症。 3.碱性化学烧伤、广泛角膜上皮糜烂。 4.眼部疲劳、眼球细胞老化。
用法用量
滴眼用。临用前，将粉未倒入溶剂瓶内，振摇溶解后使用。每二小时点一次。一次1-2滴，2-4周为一疗程，或遵医嘱。
不良反应
尚不明确。
禁忌
禁与碘化油、糜蛋白酶、胰蛋白酶配伍。
注意事项
1.制成溶液后，应在7天内使用完毕。
2.禁与碘化油、糜蛋白酶、胰蛋白酶配伍。
贮藏
密闭，在阴暗处保存。
规格
粉剂每瓶80mg，溶剂每瓶5ml
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.